Jeremy Veenstra-VanderWeele uses molecular and translational neuroscience research tools in the pursuit of new treatments for autism.
Jeremy Veenstra-VanderWeele
From this contributor
Why serotonin medications may yet help children with autism
A class of medications used to treat obsessive-compulsive disorder seems to ease compulsive behaviors in adults with autism. Why can't we tell if these medications work similarly in children with the condition?
Why serotonin medications may yet help children with autism
How to evaluate new medications for autism
There are no available medications for treating autism’s core symptoms, but there are several candidates in clinical trials. Jeremy Veenstra-VanderWeele describes the factors researchers must take into account when developing drugs for the disorder.
How to evaluate new medications for autism
Explore more from The Transmitter
When autistic kids grow up, Chapter 2: “You need to go to college”
With just a high school equivalency degree and struggling as a single mother, Tempest McDonald is forced to shift her priorities.
When autistic kids grow up, Chapter 2: “You need to go to college”
With just a high school equivalency degree and struggling as a single mother, Tempest McDonald is forced to shift her priorities.
Noncoding RNA sways core autism traits in mice
Small deletions in an X-linked RNA alter social and repetitive behaviors in male mice without broadly affecting learning or memory.
Noncoding RNA sways core autism traits in mice
Small deletions in an X-linked RNA alter social and repetitive behaviors in male mice without broadly affecting learning or memory.
Four protein synthesis pioneers win Kavli Prize in Neuroscience
Their research revealed how neurons synthesize proteins in previously unrecognized places.
Four protein synthesis pioneers win Kavli Prize in Neuroscience
Their research revealed how neurons synthesize proteins in previously unrecognized places.